NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 166 filers reported holding NOVAVAX INC in Q3 2018. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $15,000 | -51.6% | 27,882 | +66.7% | 0.00% | – |
| Q4 2018 | $31,000 | +121.4% | 16,729 | +131.9% | 0.00% | – |
| Q3 2018 | $14,000 | +40.0% | 7,214 | 0.0% | 0.00% | – |
| Q2 2018 | $10,000 | -33.3% | 7,214 | 0.0% | 0.00% | – |
| Q1 2018 | $15,000 | +66.7% | 7,214 | 0.0% | 0.00% | – |
| Q4 2017 | $9,000 | +12.5% | 7,214 | 0.0% | 0.00% | – |
| Q3 2017 | $8,000 | 0.0% | 7,214 | 0.0% | 0.00% | – |
| Q2 2017 | $8,000 | -11.1% | 7,214 | 0.0% | 0.00% | – |
| Q1 2017 | $9,000 | 0.0% | 7,214 | 0.0% | 0.00% | – |
| Q4 2016 | $9,000 | -40.0% | 7,214 | 0.0% | 0.00% | – |
| Q3 2016 | $15,000 | -65.9% | 7,214 | +18.5% | 0.00% | -100.0% |
| Q2 2016 | $44,000 | +41.9% | 6,086 | 0.0% | 0.00% | – |
| Q1 2016 | $31,000 | -39.2% | 6,086 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $51,000 | +96.2% | 6,086 | +63.0% | 0.00% | – |
| Q3 2015 | $26,000 | +136.4% | 3,734 | +293.9% | 0.00% | – |
| Q2 2015 | $11,000 | +37.5% | 948 | 0.0% | 0.00% | – |
| Q1 2015 | $8,000 | – | 948 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alden Global Capital LLC | 600,000 | $4,362,000 | 3.76% |
| DAFNA Capital Management LLC | 550,000 | $3,999,000 | 3.17% |
| BB BIOTECH AG | 8,330,000 | $60,559,000 | 2.39% |
| HARVEY CAPITAL MANAGEMENT INC | 602,750 | $4,381,000 | 2.20% |
| NORTHPOINTE CAPITAL LLC | 2,124,035 | $15,442,000 | 1.82% |
| Cormorant Asset Management, LP | 1,619,608 | $11,775,000 | 1.67% |
| WILLIAM HARRIS INVESTORS INC | 667,922 | $4,856,000 | 1.22% |
| Eventide Asset Management | 2,179,700 | $15,846,000 | 0.97% |
| SECTORAL ASSET MANAGEMENT INC | 912,305 | $6,632,000 | 0.68% |
| Rock Springs Capital Management LP | 852,500 | $6,198,000 | 0.46% |